Press-release for stocks for sny

symbols : Sny crawled time : 14:20

save search

BioSpace FDA Decision Tracker 2023: Octapharma, Tarsus, Verrica and Daiichi Sankyo
Published: 2023-07-28 (Crawled : 14:20) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K

Health Technology

| -17.38% | O: 0.47% H: 0.74% C: 0.05%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -13.89% | O: -3.09% H: 0.0% C: 0.0%
fda

Biopharma Lawsuit Tracker 2023: U.S. Chamber, Pfizer and BioNTech
Published: 2023-07-14 (Crawled : 14:20) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -12.2% | O: 0.36% H: 0.0% C: 0.0%
biopharma

Apogee Files for IPO with Promising Preclinical Immuno Asset
Published: 2023-06-23 (Crawled : 14:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -14.6% | O: -2.99% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -13.49% | O: 0.74% H: 0.0% C: 0.0%
preclinical

Sona Nanotech Elects New Board Chair and is Awarded Patent
Published: 2023-05-18 (Crawled : 14:20) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -14.37% | O: 0.16% H: 0.0% C: 0.0%
patent

Lilly’s Prevail, Doudna’s Scribe Partner on Genetic Treatments for Neuro Dise...
Published: 2023-05-17 (Crawled : 14:20) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -14.99% | O: -0.73% H: 0.0% C: 0.0%
genetic

Pharma, PBMs Blame Each Other Under Intense Scrutiny from Sanders’ Health Com...
Published: 2023-05-11 (Crawled : 14:20) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -14.77% | O: -0.28% H: 0.0% C: 0.0%
health

FDA Approves Fabry Disease Treatment from Chiesi, Protalix
Published: 2023-05-10 (Crawled : 14:20) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -16.26% | O: -1.75% H: 0.0% C: 0.0%
fda disease treatment

Regeneron Diversifies Portfolio as Eylea Revenue Takes a Hit
Published: 2023-05-05 (Crawled : 14:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -13.77% | O: 2.74% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -15.58% | O: 0.81% H: 0.0% C: 0.0%
eylea

DUPIXENT (dupilumab injection) is now approved in Canada for the treatment of adult and adolescent patients (12+) with Eosinophilic Esophagitis
Published: 2023-05-04 (Crawled : 14:20) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -14.26% | O: 1.56% H: 0.0% C: 0.0%
approved dupixent treatment canada

ServiceCore Expands Roll-off Capabilities with Acquisition of Docket – Benzinga
Published: 2023-05-01 (Crawled : 14:20) - spacfeed.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -13.33% | O: 4.08% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -15.5% | O: -1.21% H: 0.0% C: 0.0%
acquisition

Atlas Announces Closing of Acquisition of GreenSeal, Increasing Export Capacity and Strengthening its Integrated Value Chain – Marketscreener.com
Published: 2023-05-01 (Crawled : 14:20) - spacfeed.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -13.33% | O: 4.08% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -15.5% | O: -1.21% H: 0.0% C: 0.0%
capacity acquisition

Bundle of Joy
Published: 2023-05-01 (Crawled : 14:20) - spacfeed.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -13.33% | O: 4.08% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -15.5% | O: -1.21% H: 0.0% C: 0.0%

Libtayo (cemiplimab) in Combination with Chemotherapy now approved in Canada for the First-line Treatment of Advanced Non-small Cell Lung Cancer
Published: 2023-05-01 (Crawled : 14:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -13.33% | O: 4.08% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -15.5% | O: -1.21% H: 0.0% C: 0.0%
lung approved cancer cell treatment libtayo canada

The Global ELISA Market to Showcases Growth at a Significant CAGR of ~6% by 2027 | DelveInsight
Published: 2023-04-06 (Crawled : 14:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -15.73% | O: 1.36% H: 2.91% C: 2.91%
CRL | $227.55 -1.1% 0.0% 710K

Commercial Services

| 18.7% | O: -0.08% H: 0.55% C: 0.52%
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| 1.94% | O: 0.0% H: 0.86% C: 0.47%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -16.49% | O: 1.13% H: 0.0% C: 0.0%
EXAS | $63.45 0.36% 0.36% 1.6M

Health Technology

| -0.88% | O: -0.82% H: 3.93% C: 3.85%
global growth market

Thinking about trading options or stock in Regeneron Pharmaceuticals, NetEase, Netflix, Advanced Micro Devices, or Novo Nordisk?
Published: 2023-03-23 (Crawled : 14:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -5.09% | O: 5.54% H: 0.96% C: 0.96%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -5.55% | O: 6.53% H: 0.56% C: -0.54%

Dupixent Clears Phase III in Bid to Become First Biologic for COPD
Published: 2023-03-23 (Crawled : 14:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -5.09% | O: 5.54% H: 0.96% C: 0.96%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -5.55% | O: 6.53% H: 0.56% C: -0.54%
dupixent copd

Enable Biosciences Announces Relaunch of Website for Early Detection of Type 1 Diabetes
Published: 2023-03-21 (Crawled : 14:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -3.44% | O: 1.74% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -3.6% | O: 2.13% H: 0.0% C: 0.0%
diabetes

Leading Transplant Organizations Unite as GVHD Alliance, Announce Inaugural GVHD Day on February 17, 2023
Published: 2023-02-17 (Crawled : 14:20) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -1.44% | O: 1.22% H: 0.0% C: 0.0%
day

Sanofi R&D Head Steps Down Ahead of Busy 2023 Schedule
Published: 2023-02-13 (Crawled : 14:20) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -3.17% | O: -1.53% H: 0.0% C: 0.0%
sanofi